Literature DB >> 29447582

Clinical characteristics and quality of life in Chinese patients with Parkinson's disease beyond 20 years.

Ruwei Ou1, Yanbing Hou1, Wei Song1, Qianqian Wei1, Yongping Chen1, Bei Cao1, Xiaoqin Yuan1, Huifang Shang1.   

Abstract

Background The number of Parkinson's disease (PD) patients with disease duration of more than 20 years (long disease duration PDLPD) is on the rise. Objectives This study aims to describe the clinical profiles and the quality of life (QoL) of LPD patients from a cohort of the Chinese population. Methods We compared 71 LPD subjects to 60 PD patients who died less than 20 years after the onset of PD (control PDCPD). A regression model was constructed to assess the determinants for 20 years survival and the QoL of LPD patients. Results Compared to CPD patients, LPD patients exhibited a younger age at disease onset, higher total levodopa equivalent daily dose applications, more frequent motor complications, lower annual change in Unified PD Rating Scale (UPDRS) III score, as well as lower scores for 'sleep/fatigue' and 'mood/apathy' domains and higher score for 'sexual dysfunction' domain in the Non-Motor Symptom Scale (NMSS) (p < 0.05). Multivariate regression analyses indicated that a younger age at disease onset (OR = 0.520, 95%CI = 0.295-0.919, p = 0.024), lower annual change in UPDRS III score (OR = 0.009, 95%CI = 0.001-0.246, p = 0.005) and lower 'cardiovascular' score (OR = 0.552, 95%CI = 0.319-0.955, p = 0.034) were associated with 20-year survival, while UPDRS III (β = 0.320, p < 0.001) and NMSS (β = 0.549, p < 0.001) scores were associated with the PD Questionnaire 39 score in LPD. Conclusions The age at disease onset, rate of PD deterioration, and cardiovascular symptoms are the potential determinants for 20-year survival with PD. Both motor and non-motor disturbances contribute to the reduced QoL of LPD patients.

Entities:  

Keywords:  Parkinson’s disease; age at onset; cardiovascular symptom; long-term survival; quality of life

Mesh:

Year:  2018        PMID: 29447582     DOI: 10.1080/01616412.2018.1438227

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  3 in total

1.  [Application of intracranial lead reconstruction in deep brain stimulation therapy in patients with Parkinson's disease].

Authors:  Xiaobin Zheng; Lianghong Yu; Xinlong Wan; Huiqing Wang; Ting Yu; Qiu He; Zhangya Lin; Dezhi Kang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-12-30

2.  Effectiveness of Integrative Therapy for Parkinson's Disease Management.

Authors:  Yeonju Woo; Min Kyung Hyun
Journal:  Front Aging Neurosci       Date:  2019-02-26       Impact factor: 5.750

3.  Current Status of Acceptance of Disability and the Correlation With the Life Quality in Parkinson's Disease in Southwest China.

Authors:  Yan Liang; Dezhi Chen; Ruwei Ou; Bi Zhao; Wei Song; Xiaojiang Yi; Rong Yang; Xueping Chen
Journal:  Front Med (Lausanne)       Date:  2022-01-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.